Cutaneous manifestations and SARS-CoV-2 infection
References
- Ralston S.H., Penman I.D., Strachan M.W.J., Hobson R.P. (2009). Davidson Choroby wewnętrzne, t.1. Edra Urban & Partner: Wrocław.
- Murray P.R., Rosenthal K.S., Pfaller M.A. Mikrobiologia. Edra Urban & Partner: Wrocław.
- Wawrzyniak A., Kuczborska K., Lipińska-Opałka A., Będzichowska A., Kalicki B. (2019). Koronawirus 2019-nCoV - transmisja zakażenia, objawy i leczenie. Pediatr. Med. Rodz., 15: 1–5.
- Zawilińska B., Szostek S. (2020). Koronawirusy o niskiej i wysokiej patogenności, zakażające człowieka. Zakażenia XXI wieku, 3: 7–16.
- Pyrć K. (2015). Ludzkie koronawirusy. Post. Nauk Med., 28: 48–53.
- Novel coronavirus (2019-nCoV) situation report-1 21 January 2020 WHO.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4 (21.01.2020). - Weekly epidemiological update - 18 May 2021.
https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---18-may-2021 (16.05.2021). - COVID-19.
https://pl.wikipedia.org/wiki/COVID-19 (11.01.2021). - Advice for the public: Coronavirus disease (COVID-19).
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public (05.04.2020). - Krajewski P.K., Maj J., Szepietowski J.C. (2021). Cutaneous hyperaesthesia in SARS-CoV-2 infection: Rare but not unique clinical manifestation. Acta Derm. Venerol., 101: adv00366.
- Rodriguez-Cerdeira C., Uribe-Camacho B.I., Silverio-Carrasco L., Méndez W., Mahesh A.R., Tejada A., Beirana A., Martinez-Herrera E., Alba A., Arenas R., Szepietowski J. C. (2021). Cutaneous manifestations in COVID-19: Report on 31 cases from five countries. Biology, 10: 54.
- Joob B., Wiwanitkit V. (2020). COVID-19 in medical personnel: Observation from Thailand. J. Hosp. Infect., 104: 453.
- Raport zakażeń koronawirusem (SARS-CoV-2)
https://www.gov.pl/web/koronawirus/wykaz-zarazen-koronawirusem-sars-cov-2 (05.05.2020). - Casas C.G., Català A., Hernández G.C., Rodríguez-Jiménez P., Fernández-Nieto D., Rodríguez-Villa Lario A., Fernández I.N., Ruiz-Villaverde R., Falkenhain-López D., Velasco M.L., et al. (2020). Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases. Br. J. Dermatol., 183: 71–77.
- Amatore F., Macagno N., Mailhe M., Demarez B., Gaudy-Marqueste C., Grob J.J., Raoult D., Brouqui P., Richard M.A. (2020). SARS-CoV-2 infection presenting as a febrile rash. J. Eur. Acad. Dermatol. Venereol., 34: e304–e306.
- Kasperkiewicz M., Schmidt E., Fairley J.A., Joly P., Payne A.S., Yale M.L., Zillikens D., Woodley D.T. (2020). Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J. Eur. Acad. Dermatol. Venereol., 34: e302–e303.
- Tammaro A., Adebanjo G.A., Parisella F.R., Pezzuto A., Rello J. (2020). Cutaneous manifestations in COVID-19: The experiences of Barcelona and Rome. J. Eur. Acad. Dermatol. Venereol., 34: e306–e307.
- Van Damme C., Berlingin E., Saussez S., Accaputo O. (2020). Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J. Eur. Acad. Dermatol. Venereol., 34: e300–e301.
- Stefaniak A.A., Białynicki-Birula R., Krajewski P.K., Matusiak Ł., Goldust M., Szepietowski J.C. (2020). Itch in the era of COVID-19 pandemic. An unfolding scenario. Dermatol. Ther., 33: e13477.
- Krajewski P.K., Matusiak Ł., Szepietowska M., Białynicki-Birula R., Szepietowski J.C. (2020). Increased prevalence of face mask–induced itch in health care workers. Biology, 9: 451.
- Szepietowski J.C., Matusiak Ł., Szepietowska M., Krajewski P.K., Białynicki-Birula R. (2020). Face mask–induced itch: A self-questionnaire study of 2,315 responders during the COVID-19 pandemic. Acta Derm. Venerol., 100: adv00152.
- Brownstone N.D., Thibodeaux Q.G., Reddy V.D., Myers B.A., Chan S.Y., Bhutani T., Liao W. (2020). Novel coronavirus disease (COVID-19) and biologic therapy in psoriasis: Infection risk and patient counseling in uncertain times. Dermatol. Ther., 10: 339–349.
- Conforti C., Giuffrida R., Di Meo N., Zalaudek I. (2020). Management of advanced melanoma in the COVID-19 era. Dermatol. Ther., 33: 13444.
- Di Altobrando A., Patrizi A., Bardazzi F. (2020). Should SARSCoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? J. Eur. Acad. Dermatol. Venereol., 34: e295–e297.
- Türsen Ü., Türsen B., Lotti T. (2020). Coronavirus days in dermatology. Dermatol. Ther., e13438.
- Damle B., Vourvahis M., Wang E., Leaney J., Corrigan B. (2020). Clinical pharmacology perspectives on the antiviral activity of azithromycin and use in COVID-19. Clin. Pharmacol. Ther., 108: 201–211.
- Boscia C. (2020). Skin-to-skin care and COVID-19. Pediatrics, 146: 20201836.
- Joob B., Wiwanitkit V. (2020). COVID-19 can present with a rash and be mistaken for dengue. J. Am. Acad. Dermatol., 82: e177.
- [29]
Young S., Fernandez A. (2020). Skin manifestations of COVID-19. Cleve. Clin. J. Med., doi:
10.3949/ccjm.87a.ccc031.
YoungS. FernandezA. 2020 Skin manifestations of COVID-19 Cleve. Clin. J. Med. 10.3949/ccjm.87a.ccc031
DOI: https://doi.org/10.2478/ahem-2021-0040 | Journal eISSN: 1732-2693
Language: English
Page range: 1038 - 1045
Submitted on: Jan 20, 2021
Accepted on: May 17, 2021
Published on: Mar 14, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2022 Dawid Burczyk, Michalina Jakubowska, Dominika Wcisło-Dziadecka, Agnieszka Garncarczyk, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.